Harnessing Technology to Redefine Standards in GI Care

Key Takeaways

• 60M US patients suffer GI diseases, costing $111B annually.
• AI pricing tools cut patient out‑of‑pocket costs by $69 average.
• Automation cuts fill time to 1.42 days vs 5.79 average.
• Personalized education boosts adherence, lowering emergency department visits.
• Manufacturers achieve 90% dispense rate, increasing GI market share.

Summary

Gifthealth’s co‑founder John Romano outlines how AI‑driven pricing tools and automated patient‑support platforms can lower out‑of‑pocket costs and improve medication adherence for the 60 million Americans living with gastrointestinal diseases. By integrating real‑time claims adjudication, discount automation and personalized education, the solution reduces average patient spend by $69 and cuts prescription fill times to 1.42 days, far below the 5.79‑day industry norm. The model also drives a 90% brand dispense rate, boosting market share for manufacturers in a generic‑dominated market. Romano calls for broader industry collaboration to scale this frictionless pharmacy ecosystem.

Pulse Analysis

The United States faces a staggering gastrointestinal (GI) disease burden, with more than 60 million patients generating over $111 billion in annual costs. Poor medication adherence, often driven by high out‑of‑pocket expenses and limited patient education, fuels 14.5 million emergency department visits each year. Traditional pharmacy workflows struggle to address these challenges, leaving both patients and providers overwhelmed by fragmented communication and administrative overhead.

Emerging technology platforms are reshaping this landscape. AI‑powered pricing engines analyze historical drug costs, pharmacy contracts and real‑time claims data to secure the lowest possible price for each prescription, automatically applying manufacturer coupons and discounts. Simultaneously, automated outreach—via SMS, email and app notifications—delivers personalized medication guidance, refill reminders, and pre‑surgical bowel‑prep instructions. These digital interventions have already cut average patient out‑of‑pocket spend by $69 and accelerated fill times to 1.42 days, dramatically improving adherence and reducing the likelihood of costly hospital admissions.

For pharmaceutical manufacturers, the benefits extend beyond patient outcomes. Streamlined dispensing processes and targeted education have lifted brand dispense rates to 90% in a market dominated by generics, translating into measurable market‑share gains and higher gross‑to‑net margins. The success of Gifthealth’s model underscores a broader industry shift toward data‑driven, patient‑centric care that aligns payer cost‑containment goals with commercial objectives. As more stakeholders adopt AI and automation, the GI care ecosystem is poised for sustained efficiency gains and better health results nationwide.